Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed, which is a virtual clinic platform that enables clinicians to provide outstanding patient care remotely; Bioheart, which is a personal heart monitor; and Biocare health.

Earnings

Q4 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2022-02-24
REV		(EXPECTED)2022-02-24

Q3 2021		Est.		Actual		Surprise
EPS				-0.256
REV				1.807M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Biotricity Questions & Anwsers

Q: What sector and industry does Biotricity (BTCY) operate in?

Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

How do I buy Biotricity (BTCY) stock?

You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.

View our list of the best stock brokerages.

Who are Biotricity's (BTCY) competitors?

Other companies in Biotricity’s space includes: Sema4 Holdings (NASDAQ:SMFR), OptimizeRx (NASDAQ:OPRX), HealthStream (NASDAQ:HSTM), Castlight Health (NYSE:CSLT) and UpHealth (NYSE:UPH).

What is the target price for Biotricity (BTCY) stock?

The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on November 23, 2021. The analyst firm set a price target for 6.00 expecting BTCY to rise to within 12 months (a possible 41.51% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Biotricity (BTCY)?

The stock price for Biotricity (NASDAQ: BTCY) is $4.24 last updated Fri Nov 26 2021 18:00:03 GMT+0000 (Coordinated Universal Time).

Does Biotricity (BTCY) pay a dividend?

There are no upcoming dividends for Biotricity.

When is Biotricity (NASDAQ:BTCY) reporting earnings?

Biotricity’s $Q4 earnings are confirmed for after-market on February 24, 2022.

Is Biotricity (BTCY) going to split?

There is no upcoming split for Biotricity.

What sector and industry does Biotricity (BTCY) operate in?

Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD